PHARMATEKET ApS: Financial statements 2023
CVR: 15183381
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMATEKET ApS (CVR 15183381) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -27,000 and a net result of DKK 695,052 compared with DKK 242,298 the year before. Equity in the 2023 report amounted to DKK 1,555,898. The solvency ratio was 95.2%.
- Revenue
- DKK 0
- Gross Profit
- DKK -27,000
- Profit/Loss
- DKK 695,052
- Equity
- DKK 1,555,898
- Total Assets
- DKK 1,634,141
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -27 t. | 695 t. | 1.6 mio. | - |
| 2022 | 0 | -25 t. | 242 t. | 832 t. | - |
| 2021 | 0 | -24 t. | 225 t. | 589 t. | - |
| 2020 | 0 | -23 t. | 158 t. | 749 t. | - |
| 2019 | - | -23 t. | 379 t. | 5.6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMATEKET ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK 242,298.
About PHARMATEKET ApS
PHARMATEKET ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1991. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Eli Wallin and Michael Maul Svarrer. The company is owned by PHARMA NORD EXPORT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -31,250 and a net result of DKK 197,932 compared with DKK 345,812 the year before. Equity in the 2025 report amounted to DKK 1,432,509.